The research team, led by Yuan-Yuei Chen of Tri-Service General Hospital and National Defense Medical University in Taipei, together with colleagues including Chung-Ching Wang, drew on nationwide population-based databases in Taiwan to identify older workers who were diagnosed with cancer between 2004 and 2015. Taiwan’s comprehensive national health insurance system and linked administrative registries make it an unusually powerful setting for this kind of epidemiological work, allowing researchers to follow large numbers of patients over long periods with minimal loss to follow-up. The team used Cox proportional hazards models, a mainstay of survival analysis, to identify which sociodemographic, clinical, and work-related factors were associated with returning to work, and Kaplan–Meier analyses to compare long-term survival between survivors who returned to work and those who did not.

The statistical approach deserves a moment of explanation, because it shapes how the findings should be read. Cox proportional hazards models estimate the hazard—the instantaneous risk—of an event occurring at any given time, relative to a reference group, while adjusting for other variables in the model. In this study, the outcome of interest was the cause-specific hazard of returning to work during follow-up. Kaplan–Meier analyses, by contrast, produce survival curves that visually track the proportion of patients still alive over time, allowing researchers to compare mortality trajectories between groups. When the curves for two groups separate, that separation signals a difference in survival experience; when the separation widens over the follow-up period, it suggests the difference is growing.

What did the models reveal? Several factors were associated with a lower cause-specific hazard of returning to work among older survivors. Older age itself was a barrier, which is perhaps unsurprising given that advancing age brings both greater physical burdens from treatment and closer proximity to conventional retirement. Male sex was also linked to a lower hazard of returning to work, as were selected comorbidities—additional chronic conditions beyond the cancer itself. Receipt of chemotherapy or radiotherapy predicted a lower likelihood of returning to work, consistent with the well-documented fatigue, cognitive changes, and functional limitations that can accompany these treatments. Interestingly, higher income and engagement in physically demanding occupations were also associated with a reduced hazard of returning to work, a pattern that may reflect the physical toll of manual labor on older bodies recovering from cancer, as well as the possibility that higher-income workers face less financial pressure to resume employment quickly.

On the other side of the ledger, survivors diagnosed at earlier cancer stages had a higher cause-specific hazard of returning to work compared with those diagnosed at more advanced stages, and patients with colorectal, breast, or prostate cancer were more likely to return to work than the corresponding reference groups. These cancer types often carry relatively favorable prognoses and are associated with treatment regimens that may be less disabling than those for other malignancies. The stage effect is particularly intuitive: earlier-stage disease typically requires less aggressive therapy and leaves patients with better preserved functional capacity, making a return to the workplace more feasible.

The most eye-catching result, however, concerns survival. The researchers found that survival differed significantly between survivors who returned to work and those who did not, across all cancer stages. The separation of the Kaplan–Meier survival curves was more pronounced among patients with stage III or IV disease, suggesting that the association between returning to work and survival was especially visible in those with advanced cancer. Most importantly, in the Cox models, returning to work was independently associated with a reduced risk of all-cause mortality. In other words, even after accounting for other measurable factors, older survivors who went back to work died at a lower rate during follow-up than those who did not.

What could explain such an association? The authors are careful to frame returning to work as a marker that reflects both clinical recovery and broader social reintegration, rather than claiming that employment itself directly prolongs life. This distinction matters. Survivors well enough to work are, by definition, healthier on average than those who cannot work, a phenomenon epidemiologists call confounding by indication or, in this context, the healthy worker effect. Yet the relationship is unlikely to be purely one-directional. A substantial body of prior research links physical activity to lower mortality, including large analyses such as the PURE study spanning 130,000 people across 17 countries and meta-analyses of 71 prospective cohorts showing a dose-response relationship between physical activity and cancer mortality. Work, particularly for older adults, can provide structured activity, cognitive stimulation, social contact, and a sense of purpose—factors that other studies have tied to better health outcomes among cancer survivors and older adults generally.

The study also sits within a broader scientific conversation about aging and cancer. Researchers have described an aging-cancer cycle in which the biology of aging—cellular senescence, frailty, and declining tissue resilience—both increases cancer risk and complicates recovery, while cancer and its treatments can themselves accelerate aspects of aging. Comorbidity is a central player in this cycle: prior studies have shown that additional chronic conditions worsen mortality and quality of life among survivors of colorectal, breast, and other cancers. Depression, too, has been linked to elevated cancer mortality in recent meta-analyses. Against this backdrop, the new findings suggest that sustained work participation might be one tangible, measurable dimension of successful survivorship in older adults—one that occupational health services, rehabilitation programs, and employers could actively support rather than passively observe.

The practical implications are significant for societies with rapidly aging workforces. Taiwan, like many countries, is confronting the economic and social challenges of population aging, and policymakers there have explicitly promoted active aging and aging in place. If returning to work after cancer is a signal of resilience and reintegration, then survivorship-focused interventions—gradual return-to-work schedules, workplace accommodations, vocational rehabilitation, and coordination between oncology teams and occupational physicians—could help more older survivors achieve it. Prior studies of interdisciplinary rehabilitation programs in breast and prostate cancer survivors have shown that structured support can improve occupational reintegration, and research on barriers to return-to-work has repeatedly identified employer attitudes, symptom burden, and lack of guidance as modifiable obstacles. The Taiwanese study’s authors conclude that survivors who returned to work experienced more favorable survival outcomes, highlighting the importance of supportive, survivorship-focused interventions that facilitate sustained work participation among older adults. As the global population of older cancer survivors continues to grow, the question is shifting from whether elderly patients can return to work to how medicine and society can help them do so—and whether doing so might, in turn, help them live longer, more engaged lives.

Subject of Research: Return to work and long-term survival among elderly cancer survivors

Article Title: Return to work in elderly population with cancer

Article References: Chen, Y.-Y., Chen, Y.-J., Wu, W.-T., & Wang, C.-C. (2026). Return to work in elderly population with cancer. Supportive Care in Cancer, 34(10), Article 960. https://doi.org/10.1007/s00520-026-11201-z

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11201-z

Keywords: return to work, cancer survivors, elderly, survival analysis, Cox proportional hazards, Kaplan–Meier, Taiwan, comorbidity, occupational health, cancer rehabilitation, gerontology, survivorship